Mifepristone followed by misoprostol or oxytocin for second-trimester abortion: a randomized controlled trial.

Obstet Gynecol

Departments of Obstetrics and Gynecology and Nursing Administration, the Hadassah Ein-Kerem Medical Centers, the Hebrew University Medical School, Jerusalem, Israel.

Published: October 2013

Objective: To compare two methods for induction of second-trimester abortion after priming the cervix with mifepristone.

Methods: This was a randomized prospective trial carried out between January 2009 and February 2012. The participants were healthy women between 14 and 24 weeks of gestation with missed miscarriage or need for termination of pregnancy. All participants received oral 200 mg mifepristone and, after 36 hours, after randomization, were given either a high-concentration oxytocin drip (maximal dose of 150 milli-international units/min) for up to 36 hours or 800 micrograms misoprostol vaginally followed by 400 micrograms oral misoprostol every 3 hours with a maximum of four oral doses. If expulsion of the fetus was not achieved, another 200 mg mifepristone was administered and another course of misoprostol was delivered as described previously. The primary outcome measure was success expulsion of the fetus in 36 hours since starting on uterotonic agent. Secondary outcomes included time until expulsion of the fetus and rate of adverse outcomes.

Results: Success rates in the mifepristone-misoprostol and mifepristone-oxytocin arms were 100% (70/70 patients) and 95.8% (69/72), respectively (relative risk 1.043, 95% confidence interval 0.99-1.10, P=.13). Time until fetal expulsion was shorter in the mifepristone-misoprostol arm (7.0 ± 4.9 hours compared with 11.3 ± 7.4 hours, P<.001). However, the rate of adverse effects in the misoprostol group was higher than in the oxytocin group. Factors associated with a shorter time until expulsion were missed miscarriage compared with therapeutic abortion, increased ultrasonographic gestational age, and increased parity.

Conclusion: The two regimens studied had comparable efficacy for induction of second-trimester abortion; however, the mifepristone-oxytocin regimen has a longer time until expulsion but with fewer side effects.

Clinical Trial Registration: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00784797.

Level Of Evidence: : I.

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0b013e3182a2dcb7DOI Listing

Publication Analysis

Top Keywords

expulsion fetus
12
second-trimester abortion
8
200 mifepristone
8
hours
6
mifepristone misoprostol
4
misoprostol oxytocin
4
oxytocin second-trimester
4
abortion randomized
4
randomized controlled
4
controlled trial
4

Similar Publications

Aims: Ultrasound is used in the delivery room to assess fetal head position, engagement during labor, and anal sphincter injuries in the immediate postpartum period. The transperineal approach allows for direct visualization of the structures of interest without altering anatomical landmarks. Various ultrasound measurements during labor have been described in the literature, and their use varies widely across maternity units.

View Article and Find Full Text PDF

The placenta plays a pivotal role in fetal development and the dam's subsequent lactation performance, because it facilitates nutrient transfer, heat dissipation, and gas exchange with the growing fetus, and regulates key hormones essential for mammary gland development. Heat stress experienced during gestation and lactation can significantly reduce the placenta's capacity to perform these critical functions. To investigate the impact of heat stress, trials were conducted over the summer months of 2020, 2022, and 2023 in Florida.

View Article and Find Full Text PDF

Background: Missed abortion in the first trimester is characterized by the cessation of embryonic or fetal development while the cervix remains closed, often resulting in little to no bleeding. Ultrasound examinations typically reveal an empty gestational sac or an embryo/fetus that lacks cardiac activity. Misoprostol is the primary medication used to manage early pregnancy loss.

View Article and Find Full Text PDF
Article Synopsis
  • Vacuum extractors, or ventouses, are tools used during childbirth to assist with fetal delivery and are generally safe if used correctly.
  • Using the extractor in the wrong position can lead to serious complications, such as cranial vault fractures and subgaleal hematomas, which can result in perinatal death.
  • Thorough postmortem examinations are crucial for understanding the causes of death in these cases, as they can reveal improper instrument use and help reconstruct the events of the delivery.
View Article and Find Full Text PDF
Article Synopsis
  • Difficult fetal extraction during cesarean sections is mainly caused by a deeply impacted fetal head and floating fetus presentation, with limited scientific evidence supporting various management techniques.
  • Maternal complications from managing a deeply impacted fetal head include lacerations and hematomas, while neonates may suffer serious issues like hemorrhage, fractures, nerve injuries, and perinatal asphyxia.
  • The abdominovaginal delivery method is linked to higher complications, while the internal podalic version followed by pelvic extraction is a distinct approach for floating fetal presentations.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!